Bisanthraquinone glycosides of Hypericum perforatum with binding inhibition to CRH-1 receptors

  • A. Wirz
  • , U. Simmen
  • , J. Heilmann
  • , I. Çalis
  • , B. Meier
  • , O. Sticher

Research output: Contribution to journalArticlepeer-review

39 Citations (Scopus)

Abstract

Four new bisanthraquinone glycosides, S-(+)-skyrin-6-O-β-glucopyranoside (1), R-(-)-skyrin-6-O-β-glucopyranoside (2), S(+)-skyrin-6-O-β-xylopyranoside (3) and S-(+)-skyrin-6-O-β-α-arabinofuranoside (4), have been isolated from an ethanol-water (1:1, v/v) dry extract of the aerial parts of Hypericum perforatum L. The structures, were elucidated by spectroscopic methods, mainly NMR and mass spectrometry. Circular dichroism was used to determine their axial stereochemistry revealing 1 and 2 to be atropisomers. 1 and 2 inhibited [125 I]sauvagine binding to corticotropin releasing hormone (CRH-1) receptors. (C) 2000 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)941-947
Number of pages7
JournalPhytochemistry
Volume55
Issue number8
DOIs
Publication statusPublished - 12 Dec 2000

Keywords

  • Bisanthraquinone glycosides
  • CRH-1 receptor
  • Hypericaceae
  • Hypericum perforatum
  • R-(-)-skyrin-6-O-β-glucopyran oside
  • S-(+)-skyrin-6-O-α-arabinofuranosid e
  • S-(+)-skyrin-6-O-β-glucopyranoside
  • S-(+)-skyrin-6-O-β-xylopyranoside

Fingerprint

Dive into the research topics of 'Bisanthraquinone glycosides of Hypericum perforatum with binding inhibition to CRH-1 receptors'. Together they form a unique fingerprint.

Cite this